Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase 3 34Phase 1/2 15Phase NA 13Phase 1 9Phase 2/3 3Phase EARLY_PHASE1 1Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Glioma 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 3Sarcoma 2Oligodendroglioma 2Neoplasm Metastasis 2Mycosis Fungoides 2Head and Neck Neoplasms 2Ependymoma 2Breast Neoplasms 2Astrocytoma 2Rectal Neoplasms 1Radiation Fibrosis Syndrome 1Prostatic Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lung Neoplasms 1Invasive Breast Cancer 1Head and Neck Carcinoma of Unknown Primary 1Gliosarcoma 1Glioma, Subependymal 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Rituximab 5fludarabine 4Cyclophosphamide 4pembrolizumab 2Bendamustine Hydrochloride 268Ga-pentixafor 2venetoclax 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1motexafin gadolinium 1ibrutinib 1fludarabine phosphate 1daratumumab 1brexucabtagene autoleucel 1acalabrutinib 1Vincristine 1Valproic Acid 1Transplantation 1Tablets 1Surveys and Questionnaires 1Sugars 1Stem Cell Transplantation 1Simvastatin 1Roflumilast 1Ribavirin 1Radiotherapy 1Procarbazine 1Positron-Emission Tomography 1Pemetrexed 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma × Radiotherapy × Clear all
NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡